Lineage Cell Therapeutics Inc (AMEX:LCTX)
$ 0.6126 0.0052 (0.86%) Market Cap: 133.88 Mil Enterprise Value: 103.92 Mil PE Ratio: 0 PB Ratio: 1.74 GF Score: 61/100

Q4 2021 Lineage Cell Therapeutics Inc Earnings Call Transcript

Mar 10, 2022 / 09:30PM GMT
Release Date Price: $1.4 (-1.41%)
Operator

Welcome to the Lineage Cell Therapeutics Fourth Quarter and Full-Year 2021 Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available under Investors section of Lineage's website at www.lineagecell.com. This call is subject to copyright and is the property of Lineage and recordings, reproductions or transmission of this call without expressed written consent of Lineage are strictly prohibited. As a reminder, today's call is being recorded.

I would now like to introduce your host for today's call, Ioana Hone, Head of Investor Relations at Lineage. Ms. Hone, please go ahead.

Ioana C. Hone
Lineage Cell Therapeutics, Inc. - Director of IR

Thank you, Blue. Good afternoon and thank you for joining us. A press release reporting our fourth quarter and full-year 2021 financial results was issued earlier today, March 10th, 2022 and can be found on the Investors section of our website. Please note that today's discussion will contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot